Research and Markets: World Transfusion Diagnostic Testing Market 2016 - Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/lvhtxs/2016_world) has announced the addition of the "2016 World Transfusion Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report to their offering.

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Market Segmentation Analysis

  • Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.

Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment:

  1. Blood Centers
  2. Plasma Fractionation Facilities
  3. Hospitals
  4. Commercial/Private Laboratories
  5. Military Blood Banks

Current and Emerging Products

  • Analysis of current and emerging blood typing, grouping and infectious disease screening tests.
  • Review of automated and semi-automated analyzers.

Technology Review

  • Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market.
  • Comprehensive lists of companies developing or marketing new technologies and products, by test.

Worldwide Market Overview

  • Estimates of facilities performing transfusion diagnostic tests, by country.
  • Test volume and sales projections by country.

Strategic Recommendations

  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.

Companies Mentioned

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • CellMark Forensics/LabCorp
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Immucor
  • Ortho-Clinical Diagnostic
  • Proteome Sciences
  • Quest
  • Quidel
  • Roche
  • Siemens
  • Tecan
  • Thermo Fisher/Life Technologies

For more information visit http://www.researchandmarkets.com/research/lvhtxs/2016_world

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics, Blood Banking

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics, Blood Banking